Home

Rpg Life Sciences Ltd PE Ratio

Image

RPG Life Sciences Ltd

NSE: RPGLIFE

PE

37.8

Last updated on: Apr 05, 2025

Key Highlights

  • The P/E Ratio of RPG Life Sciences Ltd is 37.8 as of 05 Apr 15:30 PM .
  • The P/E Ratio of RPG Life Sciences Ltd changed from 9.7 on March 2020 to 28.9 on March 2024 . This represents a CAGR of 24.40% over 5 years.
  • The Latest Trading Price of RPG Life Sciences Ltd is ₹ 2181 as of 04 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of RPG Life Sciences Ltd

No data available

Company Fundamentals for RPG Life Sciences Ltd

Image

RPG Life Sciences Ltd

NSE: RPGLIFE

Share Price

₹ 2181.75

-130.25 (-5.63%)

stock direction

Last updated on: Apr 04, 2025

Market Price of RPG Life Sciences Ltd

1M

1Y

3Y

5Y

Monitoring RPG Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Apr 20252181.75
03 Apr 20252312
02 Apr 20252347.3
01 Apr 20252255.85
28 Mar 20252277.55
27 Mar 20252244.15
26 Mar 20252279.15
25 Mar 20252266.65
24 Mar 20252326.25
21 Mar 20252343.25

SWOT Analysis Of RPG Life Sciences Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for RPG Life Sciences Ltd

Asset Value vs Market Value of RPG Life Sciences Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
RPG Life Sciences Ltd3608
Sun Pharmaceutical Industries Ltd410142
Divis Laboratories Ltd145762
Cipla Ltd114322
Torrent Pharmaceuticals Ltd111166
Mankind Pharma Ltd101098

PE Ratio of RPG Life Sciences Ltd Explained

3608

Market cap

79

Earnings

37.8X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of RPG Life Sciences Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of RPG Life Sciences Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of RPG Life Sciences Ltd

No data available

* All values are in %

About RPG Life Sciences Ltd

  • RPG Life Sciences Limited, formerly Searle India Limited, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group.
  • The Company is engaged in manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). RPG Life Sciences Limited was incorporated on March 29, 2007 with the name 'RPG Pharmaceuticals Limited'.
  • During the year 2007-08, as per the Scheme of Arrangement, the Company acquired the Pharmaceuticals Business of Brabourne Enterprises Limited along with all assets and liabilities pertaining to that business with effect from April 2, 2007.
  • On February 13, 2008, the name of the Company was subsequently changed to RPG Life Sciences Limited. During the year 2008-09, the company increased the production capacity of Bulk Drugs and Chemicals from 62 tonnes to 71 tonnes.

RPG Life Sciences Ltd News Hub

RPG Life Sciences announces board meeting date

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 7 November 2024 Po

Read more

02 Nov 24

RPG Life Sciences soars as PAT jump 32% YoY to Rs 35 crore in Q3 FY25

Profit before tax (PBT) gained 31.93% to Rs 46.89 crore in Q3 FY25 from Rs 35.54 crore in Q3 FY24. T

Read more

27 Jan 25

RPG Life Sciences standalone net profit declines 83.76% in the September 2024 quarter

Net profit of RPG Life Sciences declined 83.76% to Rs 4.20 crore in the quarter ended September 2024

Read more

08 Nov 24

RPG Life Sciences schedules board meeting

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 24 January 2025. P

Read more

18 Jan 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of RPG Life Sciences Ltd

What is the current PE Ratio of RPG Life Sciences Ltd?

The Current PE Ratio of RPG Life Sciences Ltd is 37.77 as on 5 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 5 Apr 2025.

What was the PE Ratio of RPG Life Sciences Ltd last year?

The PE Ratio of RPG Life Sciences Ltd was 17.01 last year, now the PE ratio is 37.77, showing a year-on-year growth of 122.0%.

What does the PE Ratio of RPG Life Sciences Ltd indicate about its stock?

The PE Ratio of RPG Life Sciences Ltd is 37.77. This ratio indicates that investors are willing to pay 37.77 times the earnings per share for each share of RPG Life Sciences Ltd.

What is the PE Ratio Growth of RPG Life Sciences Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of RPG Life Sciences Ltd grew by 122.0% whereas, the EPS ratio grew by 731.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions